Genmab A/S

Genmab A/S Market capitalization

The The market capitalization of Genmab A/S (GMAB.CO) as of Nov 10, 2026 is 16.73 B USD. In the previous year, The market capitalization was 16.73 B USD — a change of 0.00% (lower).

Market capitalization

16.73 BUSD

YoY

0.00%

Last updated:

In 2025, Genmab A/S's market cap stood at 16.73 B USD, a 0.00% increase from the 16.73 B USD market cap in the previous year.

The Genmab A/S Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
16.73 B USD
Jan 1, 2019
16.73 B USD
Jan 1, 2020
16.73 B USD
Jan 1, 2021
16.73 B USD
Jan 1, 2022
16.73 B USD
Jan 1, 2023
16.73 B USD
Jan 1, 2024
16.73 B USD
Jan 1, 2025
16.73 B USD
The Genmab A/S Market capitalization history
YEARMarket capitalizationYoY
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD0.00%
16.73 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Genmab A/S's Market Capitalization

Genmab A/S's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Genmab A/S's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Genmab A/S's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Genmab A/S’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Genmab A/S stock

The market capitalization of Genmab A/S is 16.73 B USD in 2025.

The market capitalization of Genmab A/S changed from 16.73 B USD to 16.73 B USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Genmab A/S

All Key Metrics — Genmab A/S